Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0923620150150030142
Immune Network
2015 Volume.15 No. 3 p.142 ~ p.149
Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN-¥ã-secreting T-cell Ratios in Bleomycin-treated Mice
:Oh Keun-hee
:Seo Myung-Won/:Kim Young-Whan/:Lee Dong-Sup
Abstract
Lung fibrosis is a life-threatening disease caused by overt or insidious inflammatory responses. However, the mechanism of tissue injury-induced inflammation and subsequent fibrogenesis remains unclear. Recently, we and other groups reported that Th17 responses play a role in amplification of the inflammatory phase in a murine model induced by bleomycin (BLM). Osteopontin (OPN) is a cytokine and extracellular-matrix-associated signaling molecule. However, whether tissue injury causes inflammation and consequent fibrosis through OPN should be determined. In this study, we observed that BLM-induced lung inflammation and subsequent fibrosis was ameliorated in OPN-deficient mice. OPN was expressed ubiquitously in the lung parenchymal and bone-marrow-derived components and OPN from both components contributed to pathogenesis following BLM intratracheal instillation. Th17 differentiation of CD4+ ¥á¥â T cells and IL-17-producing ¥ã¥ä T cells was significantly reduced in OPN-deficient mice compared to WT mice. In addition, Th1 differentiation of CD4+ ¥á¥â T cells and the percentage of IFN-¥ã-producing ¥ã¥ä T cells increased. T helper cell differentiation in vitro revealed that OPN was preferentially upregulated in CD4+ T cells under Th17 differentiation conditions. OPN expressed in both parenchymal and bone marrow cell components and contributed to BLM-induced lung inflammation and fibrosis by affecting the ratio of pathogenic IL-17/protective IFN-¥ã T cells.
KEYWORD
Osteopontin, Pulmonary fibrosis, ¥á¥â T cells, IL-17, Th17 differentiation
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø